Rosty Raykov Fennec Pharmaceuticals Inc. (FENC) insider trading activity

Rosty Raykov is of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 88,020 shares of FENC, which is worth approximately $712,962. The most recent transaction as insider was on Jan 02, 2026, when has been sold 10,312 shares (Common Shares) at a price of $7.6 per share, resulting in proceeds of $78,371. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88K

6.69% 3M change

4.96% 12M change

Total Value Held $712,962

Rosty Raykov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Open market or private sale	$78,371 $7.6 p/Share	10,312 Reduced 10.49%	88,020 Common Shares
Jan 02 2026	BUY Exercise of conversion of derivative security	$38,215 $2.45 p/Share	15,598 Added 13.69%	98,332 Common Shares
Dec 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 5.92%	82,734 Common Shares
Dec 05 2025	SELL Open market or private sale	$75,400 $7.54 p/Share	10,000 Reduced 11.43%	77,526 Common Shares
Dec 01 2025	BUY Grant, award, or other acquisition	-	5,208 Added 5.62%	87,526 Common Shares
Nov 05 2025	SELL Open market or private sale	$81,000 $8.1 p/Share	10,000 Reduced 10.83%	82,318 Common Shares
Oct 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 5.34%	92,318 Common Shares

Oct 08 2025	BUY Exercise of conversion of derivative security	$11,292 $2.45 p/Share	4,609 Added 5.03%	87,110 Common Shares
Oct 06 2025	SELL Open market or private sale	$97,800 $9.78 p/Share	10,000 Reduced 10.81%	82,501 Common Shares
Sep 30 2025	BUY Grant, award, or other acquisition	-	5,208 Added 5.33%	92,501 Common Shares
Sep 05 2025	BUY Exercise of conversion of derivative security	$88,707 $2.45 p/Share	36,207 Added 29.32%	87,293 Common Shares
Sep 04 2025	SELL Open market or private sale	$89,200 $8.92 p/Share	10,000 Reduced 16.37%	51,086 Common Shares
Aug 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 7.86%	61,086 Common Shares
Aug 05 2025	SELL Open market or private sale	$80,900 $8.09 p/Share	10,000 Reduced 15.18%	55,878 Common Shares
Jul 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 7.33%	65,878 Common Shares
Jul 03 2025	SELL Open market or private sale	$86,100 $8.61 p/Share	10,000 Reduced 14.15%	60,670 Common Shares
Jun 30 2025	BUY Grant, award, or other acquisition	-	5,208 Added 6.86%	70,670 Common Shares
Jun 05 2025	SELL Open market or private sale	$77,800 $7.78 p/Share	10,000 Reduced 13.25%	65,462 Common Shares
May 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 6.46%	75,462 Common Shares
May 16 2025	SELL Open market or private sale	$113,002 $6.78 p/Share	16,667 Reduced 19.17%	70,254 Common Shares
May 16 2025	BUY Grant, award, or other acquisition	-	33,334 Added 27.72%	86,921 Common Shares
May 05 2025	SELL Open market or private sale	$63,099 $6.31 p/Share	10,000 Reduced 15.73%	53,587 Common Shares
Apr 30 2025	BUY Grant, award, or other acquisition	-	2,431 Added 3.68%	63,587 Common Shares
Apr 04 2025	SELL Open market or private sale	$52,500 $5.25 p/Share	10,000 Reduced 14.05%	61,156 Common Shares
Mar 31 2025	BUY Grant, award, or other acquisition	-	2,431 Added 3.3%	71,156 Common Shares

Rosty Raykov

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Value

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

Operation

Value

Type

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC

Account